DISCOVERY LABORATORIES, INC.

Address

2600 KELLY RD, STE 100
WARRINGTON, PA, 18976-3652

Information

DUNS: 171938970
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Clinical study of aerosolized KL4 surfactant for neonatal RDS and BPD prevention

    Amount: $1,948,310.00

    DESCRIPTION provided by applicant Discovery Laboratories Inc Discovery is developing a novel drug device combination therapy AEROSURF r that employs an optimized proprietary capillary aeroso ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  2. IGF OT IGF "K L SURFACTANT AEROSOL TO REDUCE INFLUENZA LUNG INJURY"

    Amount: $225,000.00

    Not Available

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Development and Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

    Amount: $1,880,292.00

    DESCRIPTION (provided by applicant): Respiratory distress syndrome (RDS) is an acute, severe pulmonary disorder that is the leading cause of morbidity and mortality in preterm infants. It is a major h ...

    SBIRPhase II2014Department of Health and Human Services
  4. KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

    Amount: $2,977,799.00

    DESCRIPTION provided by applicant Exposure to ionizing radiation from a nuclear reactor accident or deliberate terrorist actions including the detonation of andquot dirty bombsandquot is a signifi ...

    SBIRPhase II2014Department of Health and Human Services
  5. KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The threat of exposure to ionizing radiation from a nuclear reactor accident, nuclear attack, or deliberate terrorist actions including the detonation of di ...

    SBIRPhase I2012Department of Health and Human Services
  6. Development and Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

    Amount: $581,839.00

    DESCRIPTION (provided by applicant): Respiratory distress syndrome (RDS) is an acute, severe pulmonary disorder that is the leading cause of morbidity and mortality in preterm infants. It is a major h ...

    SBIRPhase I2011Department of Health and Human Services
  7. N/A

    Amount: $0.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  8. N/A

    Amount: $128,116.00

    N/A

    SBIRPhase II2000Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government